Jen Herbach has over a decade of experience in oncology drug development at biotechnology companies including Onyx/Amgen, InterMune/Genentech, Exelixis, and Amunix. She holds an MBA from Harvard Business School and a master's degree from the University of Cambridge.
Intro paths
YC
Jen went through Y Combinator (Winter 2023) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Tom Blomfield, General Partner at Y Combinator — the partner who ran Adventris Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
→
In turn, Jen can intro founders to Adventris Pharmaceuticals's investors below.
Adventris Pharmaceuticals's investors · 3
Co-founders
WC
William CollisFounder
MY
Mark YarchoanFounder